Rentokil Initial (RTO) Current Deferred Revenue (2022)
On a quarterly basis, Current Deferred Revenue changed N/A to $5.0 million in Q2 2022 year-over-year; TTM through Jun 2022 was $5.0 million, a N/A change, with the full-year FY2021 number at $2.0 million, up 150.0% from a year prior.
Rentokil Initial (RTO) has 1 years of Current Deferred Revenue data on record, last reported at $5.0 million in Q2 2022.
- Current Deferred Revenue reached $5.0 million in Q2 2022 per RTO's latest filing.
- Over the last five years, Current Deferred Revenue for RTO hit a ceiling of $5.0 million in Q2 2022 and a floor of $5.0 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 5.00 Mn |